Heads of U.S. automakers, other Michigan companies condemn racism, injustice
June 3, 2020
Walmart removes firearms, ammunition from floor display as protests rage in U.S.
June 3, 2020

Gilead’s remdesivir could see $7 billion in annual sales on stockpiling boost: analyst

Gilead Sciences Inc’s potential COVID-19 treatment, remdesivir, could bring in more than $7 billion in annual sales by 2022, spurred by governments stockpiling the drug to guard against future outbreaks, SVB Leerink said on Wednesday.

Powered by WPeMatico